Skip to content
Wholesale trade
KZActiveBIN 130440010205
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 17
To risks

ТОО "БІРЛІК-ФАРМ"

Director
Уразбаева Разия Алимбаевна
Incorporated
09.04.2013
Address
Шымкент ул. ТЕАТРАЛЬНАЯ, 21, кв. 4
РНН
582200056140

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/17

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "БІРЛІК-ФАРМ"
BIN
130440010205
Status
Active
Director
Уразбаева Разия Алимбаевна
Registration date
09.04.2013
Activity
Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями
Legal address
Шымкент ул. ТЕАТРАЛЬНАЯ, 21, кв. 4

In government contracts over 2 years

  • г.Шымкент, Абайский район, Театральная, 21, 4 matches the registered one

    contract of 01.07.2025
VAT payer
Yes, since 02.09.2019
КАТО
791910000
РНН
582200056140
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.
Procurement role
Поставщик

Activities

1
46461primary

Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
1.5M
2025
190.4K-90%
2024
1.8M-81%
2023
9.6M-18%
2022
11.7M+887%
2021
1.2M
·1.5M
2026year to date
-90%190.4K
2025
-81%1.8M
2024
-18%9.6M
2023
+887%11.7M
2022
·1.2M
2021
2026
Tax paid1,494,710 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid190,362 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid1,842,970 ₸
Penalty45,100 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid9,595,337 ₸
Penalty103,400 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid11,704,037 ₸
Penalty1,022,623 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid1,186,409 ₸
Penalty49,800 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

2
  • УР

    Уразбаева Разия Алимбаевна

    Director

Former directors

  • ШНШАНАС НҰРБОЛ ТӨЛЕГЕНҰЛЫ
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "БІРЛІК-ФАРМ" (BIN 130440010205) is an active legal entity in Шымкент, registered in 2013 (13 years on the market). Primary activity — оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями. Per open government registries as of November 7, 2026: 375 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 527,332,093 ₸. Automated screening of open registries found no risk indicators for "БІРЛІК-ФАРМ". Director on record — Уразбаева Разия Алимбаевна. Data current as of November 7, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.